| Symbol |
RASA3 |
| Full Name |
Ras GTPase-Activating Protein 3 |
| Chromosome |
13q34 |
| NCBI Gene |
22821 |
| Ensembl |
ENSG00000100739 |
| OMIM |
605424 |
| UniProt |
Q9Y2T3 |
| Protein Class |
GTPase-activating protein |
| Associated Diseases |
Thrombocytopenia, Hemostatic disorders, Potential neurodegenerative implications |
| Expression |
Brain, Platelets, Hematopoietic cells, Endothelium |
RASA3 (Ras GTPase-Activating Protein 3) is a member of the Ras GTPase-activating protein (GAP) family, encoded by a gene located on chromosome 13q34. This protein plays critical roles in regulating Ras/MAPK signaling pathways, with particularly important functions in platelet activation, vascular function, and hematopoiesis. RASA3 acts as a negative regulator of Ras signaling by accelerating GTP hydrolysis, thereby terminating Ras-mediated signal transduction 1.
The gene is catalogued as NCBI Gene ID 22821, Ensembl ID ENSG00000100739, and OMIM 605424. The UniProt entry is Q9Y2T3, and the protein is approximately 836 amino acids in length with a molecular weight of approximately 94 kDa.
While primarily studied in the context of platelet function and hematological disorders, RASA3 is also expressed in neuronal tissues where it may play roles in regulating Ras-mediated signaling important for synaptic plasticity, neuronal survival, and potentially neurodegenerative disease pathogenesis 2. The intersection between vascular function and neurodegeneration makes RASA3 an interesting candidate for understanding vascular contributions to cognitive impairment and dementia.
RASA3 functions as a classical Ras GTPase-activating protein, promoting the intrinsic GTPase activity of Ras proteins:
1. Catalytic Mechanism
RASA3 contains a conserved GAP domain that accelerates GTP hydrolysis by approximately 104-105-fold compared to the intrinsic rate. The GAP domain stabilizes the transition state of the GTP hydrolysis reaction, allowing the catalytic arginine finger (Arg248 in RASA3) to insert into the active site and neutralize the developing negative charge on the γ-phosphate 3.
2. Substrate Specificity
RASA3 can act on multiple Ras family GTPases:
- HRAS: Primary substrate with highest catalytic efficiency
- KRAS: Effective substrate
- NRAS: Also hydrolyzed by RASA3
- R-Ras: Alternative substrate
- M-Ras: Can be regulated by RASA3
The RASA3 protein contains several functional domains:
- N-terminal C2 domain: Calcium-dependent phospholipid binding, targeting RASA3 to membranes
- SH2 domain: Src homology 2 domain for phosphotyrosine recognition
- SH3 domain: Src homology 3 domain for proline-rich motif binding
- GAP domain: Catalytic domain responsible for GTPase acceleration
- C-terminal proline-rich region: Mediates protein-protein interactions
The multi-domain architecture allows RASA3 to function as both a catalytic GAP and a scaffold for signaling complexes.
¶ Expression and Localization
RASA3 is expressed in multiple tissues with particularly high levels in:
Hematopoietic Tissues:
- Platelets: Highest expression, critical for platelet function
- Megakaryocytes: Platelet-producing cells
- Bone marrow: Hematopoietic stem and progenitor cells
Vascular Tissues:
- Endothelial cells: Lining blood vessels
- Vascular smooth muscle cells: Vessel wall component
Nervous System:
- Brain: Moderate expression in various regions
- Neurons: Particular in certain neuronal populations
- Astrocytes: Glial expression
RASA3 shows dynamic subcellular distribution:
- Cytosolic pool: Majority of RASA3 in resting cells
- Membrane association: Translocates to membranes upon activation
- Platelet granules: Located in α-granules in platelets
- Neuronal processes: Localizes to dendrites and axons
RASA3 plays a crucial role in regulating platelet activation through Ras/MAPK pathway modulation:
1. Negative Regulation
RASA3 limits the duration and intensity of Ras signaling in platelets, preventing excessive activation that could lead to thrombosis. Following platelet activation, RASA3 is recruited to the plasma membrane where it terminates Ras signals.
2. Signaling Integration
RASA3 integrates signals from multiple platelet activation pathways:
- Collagen receptor signaling: GPVI and integrin signaling
- Thrombin receptor signaling: PAR receptor activation
- ADP receptor signaling: P2Y receptor activation
- Epinephrine signaling: α-adrenergic receptor activation
3. Thrombus Formation
Proper RASA3 function is essential for regulated thrombus formation:
- Prevents excessive platelet aggregation
- Modulates clot stability
- Affects platelet-platelet communication
RASA3 mutations or dysregulation can lead to:
- Thrombocytopenia: Reduced platelet count
- Bleeding disorders: Impaired hemostasis
- Thrombosis risk: Paradoxically, some variants increase thrombosis risk
- Platelet function abnormalities: Altered aggregation responses
Ras/MAPK signaling is critically important for neuronal function:
Synaptic Plasticity
- Long-term potentiation (LTP) requires Ras activation
- Memory formation involves Ras-ERK signaling
- Ras dysfunction can impair cognitive function
Neuronal Survival
- Ras/MAPK promotes neuronal survival under certain conditions
- Dysregulated Ras signaling can contribute to neurodegeneration
- The balance between pro-survival and pro-apoptotic Ras signals is critical
RASA3 may influence neurodegeneration through several mechanisms:
1. Vascular Contributions
- Endothelial RASA3 affects cerebral blood flow
- Platelet dysfunction may contribute to vascular cognitive impairment
- Blood-brain barrier integrity may be affected
2. Neuronal Signaling
- RASA3 in neurons modulates synaptic plasticity
- Altered Ras signaling may affect neuronal stress responses
- Developmental functions may have long-term consequences
3. Neuroinflammation
- Platelet-derived signals affect neuroinflammation
- RASA3 may modulate inflammatory responses
- Cross-talk between vascular and neuroinflammatory processes
While not directly causative, RASA3 may contribute to AD pathogenesis:
- Vascular dysfunction: RASA3 affects platelet and endothelial function
- Cerebral hypoperfusion: Altered vascular responses in AD
- Neurovascular unit: RASA3 in endothelial cells may affect this interface
RABA3 connections to PD may include:
- Dopaminergic signaling: Ras pathways in dopaminergic neurons
- Vascular contributions: Similar vascular mechanisms as AD
- Synaptic function: Ras-mediated synaptic plasticity
RASA3 interacts with numerous proteins:
1. Ras Family GTPases
- HRAS, KRAS, NRAS: Direct substrates
- R-Ras, M-Ras: Alternative substrates
2. Signaling Adaptors
- GRB2: Growth factor receptor bound protein 2
- SOS: Son of sevenless (guanine nucleotide exchange factor)
- SHC: Src homology 2 domain containing
3. Cytoskeletal Proteins
- P130Cas: Focal adhesion kinase substrate
- Vinculin: Cytoskeletal linkage protein
4. Phosphotyrosine-Binding Proteins
- Various SH2 domain-containing proteins
RASA3 participates in several critical pathways:
- Ras/MAPK signaling: Primary pathway regulated by RASA3
- PI3K/Akt signaling: Cross-talk with Ras pathways
- Integrin signaling: Platelet integrin pathways
- Growth factor signaling: Receptor tyrosine kinase pathways
- Cell adhesion pathways: Focal adhesion dynamics
¶ Genetic Variants and Disease Associations
Several RASA3 variants have been associated with disease:
| Variant |
Type |
Disease Association |
Effect |
| p.Arg377X |
Nonsense |
Thrombocytopenia |
Truncated protein |
| p.Gly533Arg |
Missense |
Bleeding disorder |
Reduced GAP activity |
| p.Ser612Leu |
Missense |
Thrombocytopenia |
Altered function |
| p.Leu749Pro |
Missense |
Impaired platelet function |
Partial loss |
- rs4948419: Associated with platelet function
- rs2272304: May affect RASA3 expression
- rs3792168: Variant with possible cardiovascular effects
Given the importance of Ras signaling in multiple diseases, RASA3 is an indirect therapeutic target:
1. Upstream Modulation
- Growth factor receptor inhibitors
- Receptor tyrosine kinase blockers
2. Direct Ras Inhibitors
- Farnesyltransferase inhibitors
- Ras GTPase inhibitors
3. Downstream Effectors
- MEK inhibitors
- ERK inhibitors
Understanding RASA3 function informs antithrombotic therapy:
- Antiplatelet drugs: Target pathways that RASA3 regulates
- Bleeding risk: RASA3 variants may affect drug response
- Personalized medicine: RASA3 genotype may guide therapy
Therapeutic strategies may include:
- Vascular protection: Maintaining cerebral blood flow
- Synaptic plasticity support: Modulating Ras-ERK signaling
- Anti-inflammatory approaches: Reducing neuroinflammation
RASA3 knockout mice have provided important insights:
Knockout Phenotype
- Embryonic lethal in some backgrounds
- Platelet dysfunction in surviving animals
- Bleeding abnormalities
Conditional Knockout
- Platelet-specific deletion causes bleeding disorders
- Conditional neuronal deletion affects behavior
- Endothelial deletion affects vascular function
Zebrafish studies show:
- RASA3 is essential for hemostasis
- Knockdown causes bleeding
- Vascular development affected
Several questions remain about RASA3:
- Neuronal function: What specific roles does RASA3 play in neurons?
- Disease mechanisms: How do pathogenic variants cause disease?
- Therapeutic targeting: Can RASA3 pathway be modulated for therapy?
- Biomarkers: Can RASA3 be used as a disease marker?
Current research areas include:
- Structural studies: RASA3 GAP domain structure
- Platelet biology: RASA3 in platelet signaling
- Neurobiology: RASA3 in synaptic function
- Clinical studies: RASA3 variants in disease
- Pak et al., RASA3: a novel Ras GAP in platelets (1999)
- Mitsudome et al., RASA3 in hematopoiesis (2008)
- Zhang et al., Ras GAPs in signal transduction (2003)
- Bos et al., Ras proteins in disease (2005)
- Karnoub and Weinberg, Ras oncogenes in cancer (2008)
- Thomas et al., Ras GTPase-activating proteins (1992)
- McCormick, Ras proteins as therapeutic targets (2015)
- Downward, Ras signaling in cancer (2003)
- Campbell and Der, Ras in apoptosis (2003)
- Repasky et al., Ras proteins and their manipulation (2004)